Rubraca gets EU approval

25th January 2019 Uncategorised 0

Clovis Oncology’ Rubraca has been approved by the European Commission for maintenance treatment of adults with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer.

More: Rubraca gets EU approval
Source: News